Abstract
Objective: Synthesis of some new some new morpholine linked indole-1,2,3-triazole hybrids and evaluation of their anti-cancer activity. Methods: Cu (I) catalyzed azide-alkyne cycloaddition. MTT assay was used in anticancer activity. Autodock tools were used foe docking studies. Results and Discussion: All the sixteen compounds were screened against A549 (lung), MCF-7 (breast), and HeLa (cervical) and compared with nocodazole. In addition to this tubulin polymerization inhibition assay and docking studies were performed on some active compounds. Conclusions: Synthesized some new 1,2,3-triazole hybrids and screened them for anticancer activity, tubulin polymerization inhibition, and binding interaction with tubulin. Some of the compounds were found active.
Similar content being viewed by others
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
Naaz, F., Haider, M. R., Shafi, S., and Yar, M.S., Eur. J. Med. Chem., 2019, vol. 171, pp. 310–331. https://doi.org/10.1016/j.ejmech.2019.03.025
Kaur, R., Kaur, G., Gill, R.K., Soni, R., and Bariwal, J., Eur. J. Med. Chem., 2014, vol. 87, pp. 89–124. https://doi.org/10.1016/j.ejmech.2014.09.051
Lakhdar, S., Westermaier, M., Terrier, F., Goumont, R., Boubaker, T., Ofial, A.R., and Mayr, H., J. Org. Chem., 2006, vol. 71, pp. 9088–9095. https://doi.org/10.1021/jo0614339
Diss, L.B., Robinson, S.D., Wu, Y., Fidalgo, S., Yeoman, M.S., and Patel, B.A., ACS Chem. Neurosci., 2013, vol. 4, pp. 879–887. https://doi.org/10.1021/cn4000617
de Sa, A., Fernando, R., Barreiro, E.J., Fraga, M., and Alberto, C., Mini. Rev. Med Chem., 2009, vol. 9, pp. 782–793. https://doi.org/10.2174/138955709788452649
Li, Y.-Y., Wu, H.-S., Tang, L., Feng, C.-R., Yu, J.-H., Li, Y., Yang, Y.-S., Yang, B., and He, Q.-J., Pharmacol. Res., 2007, vol. 56, pp. 335–343. https://doi.org/10.1016/j.phrs.2007.08.002
Abdel-Gawad, H., Mohamed, H.A., Dawood, K.M., and Badria, F.A.-R., Chem. Pharm. Bull., 2010, vol. 58, pp. 1529–1531. https://doi.org/10.1248/cpb.58.1529
Mohamed, M.S., Youns, M.M., and Ahmed, N.M., Med. Chem. Res., 2014, vol. 23, pp. 3374–3388. https://doi.org/10.1007/s00044-014-0916-1
Kuduk, S.D., Chang, R.K., Wai, J.M.-C., Di Marco, C.N., Cofre, V., DiPardo, R.M., Cook, S.P., Cato, M.J., Jovanovska, A., and Urban, M.O., Bioorg. Med. Chem. Lett., 2009, vol. 19, pp. 4059–4063. https://doi.org/10.1016/j.bmcl.2009.06.021
Leboho, T.C., Michael, J.P., van Otterlo, W.A., van Vuuren, S.F., and de Koning, C.B., Bioorg. Med. Chem. Lett., 2009, vol. 19, pp. 4948–4951. https://doi.org/10.1016/j.bmcl.2009.07.091
Samosorn, S., Bremner, J.B., Ball, A., and Lewis, K., Bioorg. Med. Chem., 2006, vol. 14, pp. 857–865. https://doi.org/10.1016/j.bmc.2005.09.019
Archana, K. and Rajesh, K.S., Bioorg. Chem., 2019, vol. 89, p. 103021. https://doi.org/10.1016/j.bioorg.2019.103021
Devi, N., Kaur, K., Biharee, A., and Jaitak, N., Anti-Cancer Agents Med. Chem., 2021, vol. 21, pp. 1802–1824. https://doi.org/10.2174/1871520621999210104192644
Sachdeva, H., Mathur, J., and Guleria, A., J. Chil. Chem. Soc., 2020, vol. 65, pp. 4900–4907. https://doi.org/10.4067/s0717-97072020000204900
Patil, R., Patil, S.A., Beaman, K.D., and Patil, S.A., Future Med. Chem., 2016, vol. 8, pp. 1291–1316. https://doi.org/10.4155/fmc-2016-0047
Brancale, A. and Silvestri, R., Med. Res. Rev., 2007, vol. 27, pp. 209–238. https://doi.org/10.1002/med.20080
Sang, Y.-L., Zhang, W.-M., Lv, P.-C., and Zhu, H.-L., Curr. Top Med. Chem., 2017, vol. 17, pp. 120–137.
Sunil, D. and Pooja, R.K., Mini Rev. Med. Chem., 2016, vol. 16, pp. 1470–1499.
Naaz, F., Neha, K., Haider, Md.R., and Shafi, S., Future Med. Chem., 2021, vol. 13, pp. 1795–1828. https://doi.org/10.4155/fmc-2020-0385
Pecnard, S., Hamze, A., Bignon, J., Prost, B., Deroussent, A., Gallego-Yerga, L., Peláez, R., Paik, J.Y., Diederich, M., Alami, M., and Provot, O., Eur. J. Med. Chem., 2021, vol. 223, p. 113656. https://doi.org/10.1016/j.ejmech.2021.113656
Hwang, D.J., Wang, J., Li, W., and Miller, D.D., ACS Med. Chem. Lett., 2015, vol. 6, pp. 993–997. https://doi.org/10.1021/acsmedchemlett.5b00208
Jordan, M.A., Himes, R.H., and Wilson, L., Cancer Res., 1985, vol. 45, pp. 2741–2747.
Al-Ghorbani, M., Begum, B., Zabiulla, A., Mamatha, S.V., and Khanum, S.A., J. Chem. Pharm. Res., 2015, vol. 7, pp. 281–301.
Arshad, F., Faraz Khan, Md., Akhtar, W., Mumtaz Alam, Md., Nainwal, L.M., Kaushik, S.K., Akhter, M., Parvez, S., Hasan, S.M., and Shaquiquzzaman, Md., Eur. J. Med. Chem., 2019, vol. 167, pp. 324–356. https://doi.org/10.1016/j.ejmech.2019.02.015
Reddy, T.S., Kulhari, H., Reddy, V.G., Subba Rao, A.V., Bansal, V., Kamal, A., and Shukla, R., Org. Biomol. Chem., 2015, vol. 13, pp. 10136–10149. https://doi.org/10.1039/C5OB00842E
Stefely, J.A., Palchaudhuri, R., Miller, P.A., Peterson, R.J., Moraski, G.C., Hergenrother, P.J., and Miller, M.J., J. Med. Chem., 2010, vol. 53, pp. 3389–3395. https://doi.org/10.1021/jm1000979
Bonandi, E., Christodoulou, M.S., Fumagalli, G., Perdicchia, D., Rastelli, G., and Passarella, D., Drug. Discov. Today, 2017, vol. 17, pp. 1572–1581. https://doi.org/10.1016/j.drudis.2017.05.014
Mahboob Alam, Md., Arch. Pharm., 2022, vol. 355, p. 2100158. https://doi.org/10.1002/ardp.202100158
Xu, Z., Zhao, S.J., and Liu, Y., Eur. J. Med. Chem., 2019, vol. 183, p. 111700. https://doi.org/10.1016/j.ejmech.2019.111700
Mohammed, H.H.H., El-Hafeez, A.A.A., Ebeid, K., Mekkawy, A.I., Abourehab, Md.A.S., Wafa, E.I., Alhaj-Suliman, S.O., Salem, A.K., Ghosh, P., Rahma, G.E.D.A.A., Hayallah, A.M., and Abbas, S.H., J. Enzyme Inhib. Med. Chem., 2022, vol. 37, pp. 1346– 1363. https://doi.org/10.1080/14756366.2022.2072308
Odlo, K., Hentzen, J., Chabert, J.F.D., Ducki, S., Gani, O.A.B.S.M., and Sylte, I., Bioorg. Med. Chem., 2008, vol. 16, pp. 4829–4838. https://doi.org/10.1016/j.bmc.2008.03.049
Solum, E.J., Hansen, A., and Vik, T.V., Steroids, 2014, vol. 87, pp. 46–53. https://doi.org/10.1016/j.steroids.2014.05.020
Qi, Z.Y., Hao, S.Y., Bian, H.L., Hui, L., and Chen, S.W., Bioorg. Chem., 2020, vol. 94, p.103392. https://doi.org/10.1016/j.bioorg.2019.103392
Fu, D.J., Li, P., Wu, B.W., Zhao, Ch.B., and Zang, S.Y., Eur. J. Med. Chem., 2019, vol. 165, pp. 309–322. https://doi.org/10.1016/j.ejmech.2019.01.033
Liu, Z., Zhang, J., Chen, S., Shi, E., Xu, Y., and Wan, X., Angew. Chem. Int. Ed., 2012, vol. 51, pp. 3231–3235. https://doi.org/10.1002/anie.201108763
Hamel, E., Cell Biochem. Biophys., 2003, vol. 38, pp. 1–21. https://doi.org/10.1385/CBB:38:1:1
Ravelli, R.B., Gigant, B., Curmi, P.A., Jourdain, I., Lachkar, S., Sobel, A., and Knossow, M., Nature, 2004, vol. 428, pp. 198–202. https://doi.org/10.1038/nature02393
Funding
This work was supported by regular institutional funding, and no additional grants were obtained.
Author information
Authors and Affiliations
Contributions
The author PP and SK—involved in the synthesis and characterization of the compounds; the author MS—involved in studying the anticancer activity of the compounds; the author MR—involved in docking studies and tubulin polymerization inhibition assay; the author SM—involved in designing the scheme and writing the manuscript
Corresponding author
Ethics declarations
This article does not contain any studies involving patients or animals as test objects.
Informed consent was not required for this article. No conflict of interest was declared by the authors.
Additional information
Publisher's Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Pinnoju, P., Kudikala, S., Scandakashi, M. et al. Synthesis of Morpholine Linked Indole-1,2,3-triazole Hybrids as In Vitro Tubulin Polymerization Inhibiting Agents. Russ J Bioorg Chem 50, 293–303 (2024). https://doi.org/10.1134/S1068162024020018
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162024020018